Prognosis of patients with fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: A systematic review and meta-analysis

Gastrointestinal Cancer Research

Volumn 7, Issue 2, 2014, Pages 49-54

  Njei, Basile ^a   Konjeti, Venkata Rajesh ^a   Ditah, Ivo ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE COURSE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; SENSITIVITY ANALYSIS; SURVIVAL TIME; SYSTEMATIC REVIEW;

EID: 84899838345     PISSN: 19347820     EISSN: 19347987     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. American Cancer Society: Cancer Facts and Figures 2012. Atlanta, GA, American Cancer Society, 2012
2. Edmondson HA: Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child 91:168-186, 1956
3. Craig JR: Fibro lamellar carcinoma: clinical and pathologic features, in Okuda K, Tabor E (eds): Liver Cancer. New York, NY, Churchill Livingstone, pp 255-262, 1997
4. El-Serag HB, Davila JA: Is fibrolamellar carcinoma different from hepatocellular carcinoma?-a US population-based study. Hepatology 39:798-803, 2004
5. Czauderna P, Mackinlay G, Perilongo G, et al: Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 20:2798-2804, 2002
6. Katzenstein HM, Krailo MD, Malogolowkin MH, et al: Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97:2006-2012, 2003
7. Farhi DC, Shikes RH, Murari PJ, et al: Hepatocellular carcinoma in young people. Cancer 52: 1516-1525, 1983
8. Foster JH, Berman MM:. Solid liver tumors, in Major Problems in Clinical Surgery (vol. 22). Philadelphia, W. B. Saunders, 1977, pp 111-128
9. Pinna AD, Iwatsuki S, Lee RG, et al: Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26:877-883, 1997
10. Lau WY: Primary hepatocellular carcinoma, in Blumgart LH, Fong Y (eds): Surgery of the Liver and Biliary Tract (3rd ed). London, W. B. Saunders, pp 1423-1450, 2000
11. McLarney JK, Rucker PT, Bender GN, et al: Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. Radiographics 19:453-471, 1999
12. Collier NA, Weinbren K, Bloom SR: Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1:538-540, 1984
13. Paradinas FJ, Melia WM, Wilkinson ML, et al: High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. BMJ 285:840-842, 1982
14. Soreide O, Czerniak A, Bradpiece H, et al: Characteristics of fibrolamellar hepatocellular carcinoma: a study of nine cases and a review of the literature. Am J Surg 151:518-523, 1986
15. Berman JJ: Correspondence Re: Nerlich AG Majewski S, Hunzelmann N et al. Distinctive case: excessive collagen formation in fibrolamellar carcinoma of the liver-a morphological and biochemical study. Mod Pathol 5:580, 1992. Mod Pathol 6:505-507, 1993
16. Starzl TE, Iwatsuki S, Shaw BW Jr, et al: Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 162:145-148, 1986
17. Nagorney DM, Adson MA, Weiland LH, et al: Fibrolamellar hepatoma. Am J Surg 149:113-119, 1985
18. Ringe B, Wittekind C, Weimann A, et al: Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet 175:299-305, 1992
19. Higgins J, Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available at www. cochrane-handbook.org
20. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
21. Egger M, Davey Smith G, et al: Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634, 1997
22. Eggert T, McGlynn KA, Duffy A, et al: Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10. Gut 62:1667-1668, 2013
23. Bhaijee F, Krige JE, Locketz ML, et al: Liver resection for non-cirrhotic hepatocellular carcinoma in South African patients. S Afr J Surg 49:68-74, 2011
24. Kakar S, Burgart LJ, Batts KP, et al: Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 18:1417-1423, 2005
25. Klintmalm GB: Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 228:479-490, 1998
26. Vauthey JN, Klimstra D, Franceschi D, et al: Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28-34, 1995
27. McPeake JR, O'Grady JG, Zaman S, et al: Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 18:226-234, 1993
28. Iwatsuki S, Starzl TE, Sheahan DG, et al: Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221-229, 1991
29. Haas JE, Muczynski KA, Krailo M, et al: Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64: 1082-1095, 1989
30. Weeda VB, Murawski M, McCabe AJ et al: Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma: results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience. Eur J Cancer 49:2698-2704, 2013
31. Patt YZ, Hassan MM, Lozano RD, et al: Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 21:421-427, 2003
32. Epstein BE, Pajak TF, Haulk TL, et al: Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol 22:22-28, 1999
33. Marcos-Alvarez A, Jenkins RL, Washburn WK, et al: Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg 131:292-298, 1996
34. Wood WJ, Rawlings M, Evans H, et al: Hepatocellular carcinoma: importance of histologic classification as a prognostic factor. Am J Surg 155:663-666, 1988
35. Ihde DC, Matthews MJ, Makuch RW, et al: Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy: identification of two groups of patients with prospects for prolonged survival. Am J Med 78:399-406, 1985
36. Ichikawa T, Federle MP, Grazioli L, et al: Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 213:352-361, 1999
37. Blachar A, Federle MP, Ferris JV, et al: Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology 223:532-539, 2002
38. Perez-Guillermo M, Masgrau NA, Garcia-Solano J, et al: Cytologic aspect of fibrolamellar hepatocellular carcinoma in fine-needle aspirates. Diagn Cytopathol 21:180-187, 1999
39. Mavros MN, Mayo SC, Hyder O, et al: A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg 215:820-830, 2012
40. Vivekanandan P, Torbenson M: Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Mod Pathol 21:670-5, 2008
41. Quaglia A, Bhattacharjya S, Dhillon AP: Limitations of the histopathological diagnosis and prognostic assessment of hepatocellular carcinoma. Histopathology 38:167-174, 2001
42. Monto A, Wright TL: The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28:441-449, 2001